US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

January 28, 2020

Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 02, 2020

    Hetero, Zydus Settle Novartis MS Drug Suits Before IP Trial

    Generic-drug makers Hetero and Zydus have each reached last-minute settlements to avoid an infringement trial set for Monday over their versions of Novartis Pharmaceuticals Corp.'s blockbuster multiple sclerosis drug Gilenya.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login